Bone and soft tissue tumors: the role of contrast agents for MR imaging
- 1 June 2000
- journal article
- review article
- Published by Elsevier in European Journal of Radiology
- Vol. 34 (3) , 229-246
- https://doi.org/10.1016/s0720-048x(00)00202-3
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- MR Imaging in the Follow-Up Evaluation of Aggressive Soft Tissue TumorsSeminars in Musculoskeletal Radiology, 1999
- Soft Tissue Masses: The Underutilization of SonographySeminars in Musculoskeletal Radiology, 1999
- Dynamic Contrast-Enhanced MR Imaging for Soft Tissue SarcomasSeminars in Musculoskeletal Radiology, 1999
- Imaging of Soft Tissue Tumors in the Pediatric PatientSeminars in Musculoskeletal Radiology, 1999
- Dynamic contrast‐enhanced MR imaging of musculoskeletal tumors: Basic principles and clinical applicationsJournal of Magnetic Resonance Imaging, 1996
- Dynamic contrast‐enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapyJournal of Magnetic Resonance Imaging, 1995
- First-pass images of musculoskeletal lesions: A new and useful diagnostic application of dynamic contrast-enhanced MRIMagnetic Resonance Imaging, 1994
- Factor Analysis of Dynamic Magnetic Resonance Imaging in Predicting the Response of Osteosarcoma to ChemotherapyInvestigative Radiology, 1992
- Assessment of Osteosarcoma Response to Preoperative Chemotherapy Using Dynamic FLASH Gadolinium-DTPA-Enhanced Magnetic Resonance MappingInvestigative Radiology, 1992
- Femoral infarction following intraarterial chemotherapy for osteosarcoma of the leg: a possible pitfall in magnetic resonance imagingSkeletal Radiology, 1991